Results 81 to 90 of about 8,310 (238)
RWE Energie. Kraftwerk Weisweiler
, 1994 RWE Energie Aktiengesellschaft continues the traditions of the more than 90-year-old Rheinisch-Westfaelisches Elektrizitaetswerk Aktiengesellschaft. It is the management company for the energy division of the newly-restructured RWE Group, and is one of ...
Kraftwerk Weisweiler, Eschweiler (Germany)
core
AR inhibition prevents RWE-induced accumulation of eosinophils in mice.
, 2013 (I) Determination of eosinophils in BAL. The Balb/c mice were sensitized and challenged with PBS, RWE, ARI alone, or ARI+RWE and 72 h later lungs were lavaged with ice-cold PBS and differential cell counts were performed on cytocentrifuge preparations ...
Istvan Boldogh (16539) +5 more
core +1 more source
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Aims Treatment options for metabolic dysfunction‐associated steatotic liver disease (MASLD) are limited. While glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and sodium‐glucose cotransporter‐2 (SGLT‐2) inhibitors improve cardiovascular outcomes, comparative effectiveness on liver‐related outcomes remains unclear.
Gregor A. Maier +4 more
wiley +1 more source
Frontiers in PharmacologyIntroduction: Real-world evidence (RWE) in health technology assessment (HTA) holds significant potential for informing healthcare decision-making. A multistakeholder workshop was organised by the European Health Data and Evidence Network (EHDEN) and the
Ravinder Claire +8 more
doaj +1 more source
European Journal of Haematology, EarlyView.ABSTRACT Aims Paroxysmal nocturnal haemoglobinuria (PNH) is an ultra‐rare, acquired, non‐malignant haematological disorder that, if left untreated, can lead to significant morbidity. This systematic literature review (SLR) summarized real‐world evidence (RWE) for pegcetacoplan, a complement 3/3b inhibitor (C3i) available since 2021.
Juan Carlos Vallejo Llamas +4 more
wiley +1 more source
Real-World Data and Real-World Evidence in Healthcare in the United States and Europe Union
BioengineeringThe use of real-world data (RWD) for healthcare decision-making is complicated by concerns regarding whether RWD is fit-for-purpose or is of sufficient validity to support the creation of credible RWE.
Kelly H. Zou, Marc L. Berger
doaj +1 more source
RWE Rheinbraun. Geschaeftsbericht 2002
, 2003 SIGLEAvailable from TIB Hannover / FIZ - Fachinformationszzentrum Karlsruhe / TIB - Technische ...
RWE Rheinbraun AG, Koeln (Germany)
core
Biological processes altered by RWE challenge.
, 2013 Genes altered by RWE challenge were analyzed using the Ingenuity Pathway Analysis knowledge database and grouped into biological processes as shown.
Bruce Luxon (368507) +5 more
core +1 more source
The SWITCH algorithm: An expert consensus on treat‐to‐target criteria for chronic prurigo
Journal of the European Academy of Dermatology and Venereology, EarlyView.The SWITCH project assessed patients' most distressing symptoms and therapy goals, followed by an expert‐based consensus procedure to define T2T criteria for patients with chronic prurigo (CPG)/prurigo nodularis. Based on these validated criteria, a 4‐step SWITCH algorithm was established to enhance CPG therapy outcomes and reduce patient burden ...
Lea S. Stahl +16 more
wiley +1 more source
Generalizability in real‐world trials
Clinical and Translational ScienceReal‐world evidence (RWE) trials have a key advantage over conventional randomized controlled trials (RCTs) due to their potentially better generalizability.
Anatol‐Fiete Näher +3 more
doaj +1 more source